التفاصيل البيبلوغرافية
العنوان: |
Figure S3 from Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody |
المؤلفون: |
Shahram Salek-Ardakani, John C. Lin, Arvind Rajpal, Eugenia Kraynov, Jeffrey Chou, Jerry D. Clark, Allison Xu, Christopher P. Dillon, Natalija Budimir, Brent Kern, Bart Jessen, Cris Kamperschroer, Sherman M. Chin, Christopher R. Kimberlin, Joyce Chou, HoangKim Nguyen, Yasmina Abdiche, Sawsan Youssef, Amir A. Al-Khami |
بيانات النشر: |
American Association for Cancer Research (AACR), 2023. |
سنة النشر: |
2023 |
الوصف: |
Supplementary Figure 3 shows the analysis of the primary structure of sasanlimab by LC-MS peptide mapping. |
URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fe32b1646ca3f9cae8a0e42986063e1 https://doi.org/10.1158/1535-7163.22521589.v1 |
حقوق: |
OPEN |
رقم الأكسشن: |
edsair.doi.dedup.....2fe32b1646ca3f9cae8a0e42986063e1 |
قاعدة البيانات: |
OpenAIRE |